These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 920708)

  • 1. Severe chronic active liver disease. Prognostic significance of initial morphologic patterns.
    Schalm SW; Korman MG; Summerskill WH; Czaja AJ; Baggenstoss AH
    Am J Dig Dis; 1977 Nov; 22(11):973-80. PubMed ID: 920708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of bridging necrosis in chronic active hepatitis.
    Okuno T; Okanoue T; Takino T; Mori K
    Gastroenterol Jpn; 1983 Dec; 18(6):577-84. PubMed ID: 6671513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroid-treated chronic active hepatitis in remission: uncertain prognosis of chronic persistent hepatitis.
    Czaja AJ; Ludwig J; Baggenstoss AH; Wolf A
    N Engl J Med; 1981 Jan; 304(1):5-9. PubMed ID: 7432437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remission.
    Czaja AJ; Ammon HV; Summerskill WH
    Gastroenterology; 1980 Mar; 78(3):518-23. PubMed ID: 7351290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis.
    Perdigoto R; Carpenter HA; Czaja AJ
    J Hepatol; 1992 Mar; 14(2-3):325-31. PubMed ID: 1500696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in the morphological spectrum and clinical outcome of chronic liver disease in hepatitis B-positive and B-negative renal transplant recipients.
    Rao KV; Kasiske BL; Anderson WR
    Transplantation; 1991 Feb; 51(2):391-6. PubMed ID: 1994533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients.
    Rao KV; Anderson WR; Kasiske BL; Dahl DC
    Am J Med; 1993 Mar; 94(3):241-50. PubMed ID: 8452147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome.
    Geubel AP; Baggenstoss AH; Summerskill WH
    Gastroenterology; 1976 Sep; 71(3):444-9. PubMed ID: 950095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic study of chronic active hepatitis C; comparison with chronic active hepatitis B.
    Hahm KB; Chon CY; Kim WH; Han KH; Chung JB; Lee SI; Moon YM; Kang JK; Park IS; Choi HJ
    Korean J Intern Med; 1992 Jul; 7(2):102-10. PubMed ID: 1306071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamics of chronic active hepatitis with varying degrees of severity].
    Serov VV; Aprosina ZG; Popov MS; Popova IV; Tikhonova GN
    Arkh Patol; 1981; 43(8):12-27. PubMed ID: 6457594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of customary treatment in chronic active liver disease: causes and management.
    Schalm SW; Ammon HV; Summerskill WH
    Ann Clin Res; 1976 Jun; 8(3):221-7. PubMed ID: 793499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednisone treatment of chronic liver disease. I. Chronic aggressive hepatitis as a therapeutic marker.
    Schlichting P; Fauerholdt L; Christensen E; Poulsen H; Juhl E; Tygstrup N
    Liver; 1982 Jun; 2(2):104-12. PubMed ID: 7176839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic patterns of liver disease in hemophiliacs, with special reference to morphologic characteristics of non-A, non-B hepatitis.
    Bianchi L; Desmet VJ; Popper H; Scheuer PJ; Aledort LM; Berk PD
    Semin Liver Dis; 1987 Aug; 7(3):203-9. PubMed ID: 3120318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphologic evolution of CAH with and without therapy. A two year follow-up.
    Celle G; Volpi C; Testa R; Dodero M
    Hepatogastroenterology; 1980 Aug; 27(4):283-5. PubMed ID: 7203364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.
    Schalm SW; Summerskill WH; Gitnick GL; Elveback LR
    Gut; 1976 Oct; 17(10):781-6. PubMed ID: 793956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and early prognosis of esophageal varices in severe chronic active liver disease (CALD) treated with prednisone.
    Czaja AJ; Wolf AM; Summerskill WH
    Gastroenterology; 1979 Oct; 77(4 Pt 1):629-33. PubMed ID: 313890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognosis of chronic aggressive hepatitis. A clinical and morphological follow-up study.
    Dietrichson O; Christoffersen P
    Scand J Gastroenterol; 1977; 12(3):289-95. PubMed ID: 866990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated cryptogenic chronic active hepatitis.
    Czaja AJ; Taswell HF; Rakela J; Schimek CM
    Mayo Clin Proc; 1990 Oct; 65(10):1303-13. PubMed ID: 2170781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term prognosis of chronic B and C viral hepatitis].
    Ohlen J; Liegl JM; Selmair H
    Leber Magen Darm; 1995 Sep; 25(5):205-10. PubMed ID: 7500807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution.
    Baggenstoss AH; Soloway RD; Summerskill WH; Elveback LR; Schoenfield LJ
    Hum Pathol; 1972 Jun; 3(2):183-98. PubMed ID: 5028616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.